BP000146-CYT-347: Recombinant Human Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The Biological Activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEKa cells).Significant STAT3 activation is observed with 100 ug/ml of recombinant human IL-20 corresponding to a Specific Activity of 10,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000146-CYT-379: Recombinant Mouse Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The biological activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a specific activity of 1,000 U/mg of Interleukin-20 recombinant mouse.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000149-CYT-515: Recombinant Human Interleukin-24 (IL-24) Protein
Source: E. coli-derived.
Measured by its ability to bind to the cell receptor of Capan-1 cells line resulted in Stat-3 activation. The ED50 for this effect is typically 1 ug/ml corresponding to a Specific Activity of 1 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000151-CYT-104: Recombinant Human IL-28A, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000151-CYT-602: Recombinant Human IL-28A
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000152-CYT-117: Recombinant Human IL-29, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000152-CYT-603: Recombinant Human IL-29
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP001338-PRO-431: Recombinant Human Leukocyte-Associated Immunoglobulin-Like Receptor 1 (LAIR1) Protein
Source: Escherichia Coli-derived.
Purity: > 95% by SEC-HPLC and SDS-PAGE.BP000133-CYT-100: Recombinant Human Interleukin-10 (IL-10) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of MC/9 cells (mouse mast cell line) in the presence of 200 pg/ml IL-4, and is typically 0.3-1.5 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP002450-CYT-105: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.1-1 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.